œŽ@–¼
  ŒF’J@‰Ãl
  Yoshito Kumagai
   
œŠ@‘®
  ’}”g‘åŠw@‘åŠw‰@
lŠÔ‘‡‰ÈŠwŒ¤‹†‰ÈiŽÐ‰ïˆãŠwŒnj
¶–½ƒVƒXƒeƒ€ˆãŠwêU
ŠÂ‹«ˆãŠw•ª–ì@ŠÂ‹«ˆãŠw
   
œE@–¼
  ‹³ Žö
   
œŠw@ˆÊ
  –òŠw”ŽŽm(•Ÿ‰ª‘åŠw)
   
œê–啪–ì
  •ªŽqŠÂ‹«“Å«ŠwAŠÂ‹«ˆãŠw
   
œŒ¤‹†ƒe[ƒ}
 

e“d«ŠÂ‹«•¨‚É‚æ‚é–|–óŒãCü‚Æe“dŽqƒVƒOƒiƒ‹§Œä‚ÉŠÖ‚í‚é×–E“àˆöŽq

   
œŠ‘®Šw‰ïEŠw‰ï–ðˆõ
  E“ú–{‰q¶Šw‰ï@•]‹cˆõ@
E“ú–{–òŠw‰ïŠÂ‹«E‰q¶•”‰ï@í”C¢˜bl
E“ú–{ƒgƒLƒVƒRƒƒW[Šw‰ï@—Ž–
E“ú–{”÷—ÊŒ³‘fŠw‰ï@•]‹cˆõ
E•ªŽq—\–hŠÂ‹«ˆãŠwŒ¤‹†‰ï@•]‹cˆõ
   
œ’˜‘E˜_•¶
  Iwamoto N et al. Chemical knockdown of protein tyrosine phosphatase 1B by 1,2-naphthoquinone through covalent modification causes persistent transactivation of epidermal growth factor receptor. J Biol Chem 2007; 282: 33396-33404.
  Taguchi K et al. An approach to evaluate two-electron reduction of 9,10-phenanthraquinone and redox activity of the hydroquinone associated with oxidative stress. Free Radic Biol Med 2007; 43: 789-799.
  Kikuno S et al. 1,2-Naphthoquinone activates vanilloid receptor 1 through increased protein tyrosine phosphorylation, leading to contraction of guinea pig trachea. Toxicol Appl Pharmacol 2006; 210:47-54.
  Kumagai Y, Sumi D, Arsenic:Signal Transduction,Transcription Factor, and Biotransformation Involved in Cellular Response and Toxicity. Annu Rev Pharmacol Toxicol. 2007;47:243-262.
   
œŠwpŠÖŒWŽóÜ
 

•Ä‘MerckŽÐ“Á•ÊŒ¤‹†ˆõÜi1990.5j@@
“ú–{‰q¶Šw‰ï§—ãÜi2002.3j
“ú–{–òŠw‰ïŠwpU‹»Üi2009.3j
“ú–{ƒgƒLƒVƒRƒƒW[Šw‰ï“cç³Üi2010.6j

   
œtelEfax
  tel : 029-853-3133E3297
  fax : 029-853-3133
   
œƒ[ƒ‹ƒAƒhƒŒƒX
  yk-em-tumd.tsukuba.ac.jp

[—ª—ð]
1978.3
²‰ê¼‚“™ŠwZ‘²‹Æ
1982.3
•Ÿ‰ª‘åŠw–òŠw•”»–ò‰»Šw‰È ‘²‹Æ
1988.3
•Ÿ‰ª‘åŠw‘åŠw‰@–òŠwŒ¤‹†‰È
”ŽŽm‰Û’ö–òŠwêU C—¹
1989.4
ƒJƒŠƒtƒHƒ‹ƒjƒA‘åŠw
ƒƒTƒ“ƒ[ƒ‹ƒXZiUCLAj
ˆãŠw•”•ªŽq–ò—Šw”ŽŽmŒ¤‹†ˆõ
1992.4
‹ŒŠÂ‹«’¡‘—§ŠÂ‹«Œ¤‹†Š
’nˆæŠÂ‹«•”Žå”CŒ¤‹†ˆõ
1994.12
’}”g‘åŠwuŽt@ŽÐ‰ïˆãŠwŒn
1999.1
’}”g‘åŠw•‹³Žö@ŽÐ‰ïˆãŠwŒn
2003.12
’}”g‘åŠw‹³Žö ŽÐ‰ïˆãŠwŒn
2004.4@@@
’}”g‘åŠw‘åŠw‰@lŠÔ‘‡‰ÈŠwŒ¤‹†‰È@‹³Žö